Combination therapy with AZD-5582 reverses latency in ART-suppressed rhesus macaques Aug. 3, 2022 Investigators from Emory University and affiliated organizations presented preclinical data for the IAP inhibitor AZD-5582 (AstraZeneca), which has previously demonstrated the ability to systemically reverse latency in animal models of HIV. Read More
Multiclade env-gag VLP mRNA vaccine is safe, immunogenic and protects macaques from SHIV infection Dec. 29, 2021
Sequential immunization strategy for HIV-1 yields off-target effects and low protection in macaques Dec. 29, 2021
RSS